Show simple item record

dc.contributor.authorBagheri, Vahid
dc.contributor.authorAskari, Azam
dc.contributor.authorArababadi, Mohammad Kazemi
dc.contributor.authorKennedy, Derek
dc.date.accessioned2017-05-03T11:12:42Z
dc.date.available2017-05-03T11:12:42Z
dc.date.issued2014
dc.identifier.issn0198-8859
dc.identifier.doi10.1016/j.humimm.2014.02.018
dc.identifier.urihttp://hdl.handle.net/10072/63876
dc.description.abstractThe current literature describes pivotal mechanisms in which hepatitis B virus (HBV) induces liver diseases including inflammation, cirrhosis and hepatocellular carcinoma (HCC). It appears that differences in genetic and immunological parameters between patients and controls may be responsible for inducing the prolonged forms of the infection. Previous studies demonstrated that Toll-Like Receptors (TLRs) play key roles in viral recognition and inducing appropriate immune responses. Therefore, TLRs can be considered as key sensors for HBV recognition and subsequent induction of immune responses against this virus. It has also been shown that the TLR2 detects several microbial PAMPs either in its homodimer form or in a heterodimer with TLR1 or TLR6 and subsequently activates NF-jB in a MYD88 dependent manner. Therefore, defective TLR2 expression may result in impaired immune responses against HBV which is reported in long-term forms of hepatitis B. This review presents the recent data regarding the status and important roles played by TLR2 in HBV recognition and induction or suppression of immune responses against HBV as well as its roles in the pathogenesis of cirrhosis and HCC in prolonged hepatitis B forms.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.publisherElsevier
dc.publisher.placeUnited States
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom549
dc.relation.ispartofpageto554
dc.relation.ispartofissue6
dc.relation.ispartofjournalHuman Immunology
dc.relation.ispartofvolume75
dc.rights.retentionY
dc.subject.fieldofresearchMedical Virology
dc.subject.fieldofresearchImmunology
dc.subject.fieldofresearchcode110804
dc.subject.fieldofresearchcode1107
dc.titleCan Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.hasfulltextNo Full Text
gro.griffith.authorKennedy, Derek D.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record